Evidence from in vitro studies indicates that TRIM29 might stabilize disheveled 2, which negatively regulates GSK3β activity in the WNT-β-catenin signalling pathway, resulting in high expression levels of β-catenin in pancreatic cancers [13]. Here, TRIM29 is linked to pancreatic neoplasm.